This new weight loss drug ETF bets big on two of the industry's leading players

1 month ago 62
Dokky PRO Bookcase Shop
While Novo Nordisk and Eli Lilly have soared in the past year, Roundhill Investments sees bigger gains ahead for the GLP-1 drugmakers.

BankB.it shares this Content with License.

Read Entire Article

This new weight loss drug ETF bets big on two of the industry's leading players